DLH is a comprehensive health solutions and services provider that delivers a full range of technology-enabled health services across various civilian agencies, the military health system, and the Veterans Administration. The Company's services range from providing virtual pharmacy health consultation for CHAMPVA beneficiaries to veteran pharmacy fulfillment and medical logistics; conducting scientific research and clinical trials toward disease prevention and health promotion; performing medical research and development and enhancing health information technology systems (including telemedicine and electronic health records); and evaluating policy deployment and compliance with applicable protocols and guidelines, with a goal of enhancing the Company's readiness posture while providing safe, effective and integrated solutions and services to the public, armed service members, and veterans who have secured this nation's freedom. DLH has over 2,200 employees serving numerous government agencies.

Company profile

Zachary Parker
Fiscal year end
Former names
DLH Solutions, Inc. • Danya International, LLC • Social & Scientific Systems, Inc. • Irving Burton Associates, LLC ...
IRS number

DLHC stock data


2 Aug 22
12 Aug 22
30 Sep 22
Quarter (USD) Jun 22 Mar 22 Dec 21 Sep 21
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Sep 21 Sep 20 Sep 19 Sep 18
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
4 Aug 22 Jacqueline S. Everett Common Stock Option exercise Acquire M No No 8.02 25,000 200.5K 25,000
4 Aug 22 Jacqueline S. Everett Employee Stock Options Common Stock Option exercise Dispose M No No 8.02 25,000 200.5K 225,000
7 Jun 22 Kathryn M. JohnBull Common Stock Payment of exercise Dispose F No No 17.25 31,119 536.8K 321,881
7 Jun 22 Kathryn M. JohnBull Common Stock Option exercise Acquire M No No 1.34 191,000 255.94K 353,000
7 Jun 22 Kathryn M. JohnBull Employee Stock Options Common Stock Option exercise Dispose M No No 1.34 191,000 255.94K 0
2 Mar 22 Frederick Gerald Wasserman Common Stock Sell Dispose S No No 17.5 1,885 32.99K 232,222
1 Mar 22 Frederick Gerald Wasserman Common Stock Sell Dispose S No No 17.5 50 875 234,107
28 Feb 22 Frederick Gerald Wasserman Common Stock Sell Dispose S No No 17.5 5,500 96.25K 234,157
10 Feb 22 Frederick Gerald Wasserman Common Stock Sell Dispose S No No 18 2,565 46.17K 239,657
9 Feb 22 Frederick Gerald Wasserman Common Stock Sell Dispose S No No 17.92 15,000 268.8K 242,222
13F holders Current Prev Q Change
Total holders 0 0
Opened positions 0 0
Closed positions 0 0
Increased positions 0 0
Reduced positions 0 0
13F shares Current Prev Q Change
Total value 0 0
Total shares 0 0
Total puts 0 0
Total calls 0 0
Total put/call ratio
Largest owners Shares Value Change
Largest transactions Shares Bought/sold Change

Financial report summary

  • A significant portion of our revenue is concentrated in a small number of contracts and we could be seriously harmed if we were unable to continue providing services under, or unsuccessful in our recompete efforts on, these contracts.
  • The U.S. government may prefer veteran-owned, minority-owned, small and small disadvantaged businesses; therefore, we may have fewer opportunities to bid for or could lose a portion of our existing work to small businesses.
  • Loss of our GSA schedule contracts or other contracting vehicles could impair our ability to win new business and perform under existing contracts.
  • Future legislative or government budgetary and spending changes could negatively impact our business.
  • The markets in which we operate are highly competitive, and many of the companies we compete against have substantial resources. Further, the U.S. Government contract bid process is highly competitive, complex and sometimes lengthy, and is subject to protest and implementation delays.
  • Our business may suffer if we or our employees are unable to obtain and maintain the necessary security clearances or other qualifications required to perform services for our clients.
  • Our business is regulated by complex federal procurement and contracting laws and regulations, and we are subject to periodic compliance reviews by governmental agencies.
  • We may not receive the full amounts authorized under the contracts included in our backlog, which could reduce our revenue in future periods below the levels anticipated.
  • Our business growth and profitable operations require that we develop and maintain strong relationships with other contractors with whom we partner or otherwise depend on.
  • Restrictions on or other changes to the federal government’s use of service contracts may harm our operating results.
  • Our earnings and margins may vary based on the mix of our contracts and programs.
  • Our employees, or those of our teaming partners, may engage in misconduct or other improper activities which could harm our business.
  • If we are unable to attract qualified personnel, our business may be negatively affected.
  • If our subcontractors do not perform their contractual obligations, our performance as a prime contractor and our ability to obtain future business could be materially and adversely impacted and our actual results could differ materially and adversely from those anticipated.
  • Changes to U.S. tax laws may adversely affect our financial condition or results of operations and create the risk that we may need to adjust our accounting for these changes.
  • We are highly dependent on the proper functioning of our information systems.
  • Our systems and networks may be subject to cybersecurity breaches.
  • Failure to adequately protect, maintain, or enforce our rights in our intellectual property may adversely limit our competitive position.
  • We may have difficulty identifying and executing acquisitions on favorable terms and therefore may grow at slower than anticipated rates.
  • We may have difficulty integrating the operations of companies we acquire, which could cause actual results to differ materially and adversely from those anticipated.
  • We have a substantial amount of goodwill on our balance sheet. Future write-offs of goodwill may have the effect of decreasing our earnings or increasing our losses.
  • We have incurred debt in connection with acquisitions and we must make the scheduled principal and interest payments on the facility and maintain compliance with other debt covenants.
  • Our stock price may be volatile and your investment in our common stock may suffer a decline in value.
  • Since we have not paid dividends on our common stock, you cannot expect dividend income from an investment in our common stock.
  • We may issue preferred stock with rights senior to our common stock, which may adversely impact the voting and other rights of the holders of our common stock.
  • The exercise of our outstanding common stock options and warrants may depress our stock price and dilute your ownership of the Company.
  • Anti-takeover provisions in our Articles of Incorporation make a change in control of our Company more difficult.
  • Our executive officers, directors and significant stockholders will be able to influence matters requiring stockholder approval.
  • We may experience fluctuations in our revenues and operating results from period to period.
  • Our profits and revenues could suffer if we are involved in legal proceedings, investigations, and disputes.
  • We are dependent upon certain of our management personnel and do not maintain "key personnel" life insurance on our executive officers.
  • We may not be fully covered by the insurance we procure and our business could be adversely impacted if we were not able to renew all of our insurance plans.
  • Our financial condition may be affected by increases in employee healthcare claims and insurance premiums, and workers' compensation claims and insurance rates.
  • We are exposed to increased costs and risks associated with complying with increasing and new regulation of corporate governance and disclosure standards.
Management Discussion
  • The Company uses EBITDA as a supplemental non-GAAP measures of our performance. The Company defines EBITDA as net income excluding (i) interest expense, (ii) provision for or benefit from income taxes, if any, and (iii) depreciation and amortization.
  • On a non-GAAP basis, Earnings Before Interest Taxes Depreciation and Amortization (“EBITDA”) for the year ended September 30, 2021 was approximately $25.3 million, an increase of approximately $4.9 million, or 23.8%, over the prior fiscal year. This increase was principally due to the contribution of IBA and effective management of general and administrative expenses.
  • We incurred $1.1 million of corporate development costs for the year ended September 30, 2021, and $0.9 million in the fiscal year ended September 30, 2020. We are excluding corporate development costs from this measure because they were incurred as a result of specific events, do not reflect the costs of our operations, and can affect the period-over-period assessment of operating results. We are reporting this non-GAAP metric to demonstrate the impact of these events.

Content analysis

H.S. freshman Avg
New words: America, biological, bolster, closeout, combat, congressionally, COVID, driven, external, furnished, HIV, holder, Kevin, Letter, nutrition, participation, spent, supply, surrendered, Wilson
Removed: broad, FDIC, Jersey